Hibercell, Inc.

21 patents currently held · Updated Nov 14, 2026

2 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jun 2027

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 6, 2026
The maintenance fee for Aminopyridine Derivatives as Phosphatidylinositol Phosphate Kinase Inhibitors (US 11,667,651) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
1 fee due May 14, 2027
The maintenance fee for Beta Glucan Immunopharmacodynamics (US 11,815,435) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
2 fees due Sep 5 to 10, 2027 · next Sep 5

Which patents, and when each one lapses · Pro

Recent changes

1 term has ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,272,101	Glucan Preparations In force Term ends Jun 15, 2027 · High confidence	In force	Term ends Jun 15, 2027	High confidence
US 7,981,447	Particulate-Soluble Glucan Preparation In force Term ends Oct 14, 2028 · High confidence	In force	Term ends Oct 14, 2028	High confidence
US 9,610,303	Glucan preparations In force Term ends Apr 22, 2029 · High confidence	In force	Term ends Apr 22, 2029	High confidence
US 9,694,070	Compositions Including Beta-Glucans and Methods of Use In force Term ends Sep 7, 2032 · High confidence	In force	Term ends Sep 7, 2032	High confidence
US 9,943,607	Beta-Glucan Compounds, Compositions, and Methods In force Term ends Sep 7, 2032 · High confidence	In force	Term ends Sep 7, 2032	High confidence
US 10,166,289	Compositions Including Beta-Glucans and Method of Use In force Ends no later than Sep 7, 2032 · Medium confidence	In force	Ends no later than Sep 7, 2032	Medium confidence
US 12,390,526	Methods for Identifying Beta-Glucan Binding to Immune Cells In force Term ends Mar 18, 2033 · High confidence	In force	Term ends Mar 18, 2033	High confidence
US 11,229,701	Methods for Identifying Beta-Glucan Binding to Immune Cells In force Term ends Feb 27, 2034 · High confidence	In force	Term ends Feb 27, 2034	High confidence
US 9,885,726	Beta-Glucan Assay Methods In force Term ends Dec 1, 2034 · High confidence	In force	Term ends Dec 1, 2034	High confidence
US 10,092,646	Compositions and Methods for Beta-Glucan Immunotherapy In force Term ends Dec 11, 2034 · High confidence	In force	Term ends Dec 11, 2034	High confidence

10 of 21 patents shown.

Pro members see all 21.

Pro members: see all 21 patents

Also on record, not counted in the 21: 2 patents in force now held by others · 1 lapsed for an unpaid fee · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 6 abandoned · 1 no status recorded

List them